Related Experiment Video
Updated: May 13, 2026
Real-time Quaking-induced Conversion Assay for Detection of CWD Prions in Fecal Material
Published on: September 29, 2017
Advances in the development of a screening test for variant Creutzfeldt-Jakob disease
Alexander H Peden1, Mark W Head, Michael Jones
1Postdoctoral Research Fellow University of Edinburgh, National CJD Surveillance Unit (NCJDSU), School of Molecular and Clinical Medicine (Pathology), Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK +44 0131 537 1980 ; +44 0131 343 1404 ; A.Peden@ed.ac.uk.
Insights
Variant Creutzfeldt-Jakob disease (vCJD) poses diagnostic challenges due to its widespread infectious agent and lack of immune response. Developing a blood-screening assay is crucial given its transmission via blood transfusion.
Area of Science:
- Neuroscience
- Infectious Diseases
- Medical Diagnostics
Background:
- Variant Creutzfeldt-Jakob disease (vCJD) is a fatal neurodegenerative prion disease.
- Diagnostic challenges persist due to uncertainties in prevalence, incubation periods, and genotype variations.
- The vCJD infectious agent is detectable in peripheral tissues but does not elicit a detectable immune response.
Purpose of the Study:
- To review the progress in developing blood-screening assays for vCJD.
- To discuss the evaluation protocols for these diagnostic tests.
- To address the urgent need for a reliable vCJD blood test.
Main Methods:
- Review of current research and development in vCJD diagnostic testing.
- Analysis of established and proposed protocols for test evaluation.
- Synthesis of information on prion disease detection.
Main Results:
- Significant advancements have been made in developing potential blood-screening tests for vCJD.
- Various evaluation protocols are being devised to assess the efficacy of these tests.
- The review highlights the ongoing efforts to overcome diagnostic hurdles.
Conclusions:
- The development of a vCJD blood-screening assay is a critical unmet need.
- Continued research and standardized evaluation protocols are essential for diagnostic progress.
- Effective screening could mitigate the risk of vCJD transmission through blood transfusion.
Abstract:
Variant Creutzfeldt-Jakob disease (vCJD) is a transmissible neurodegenerative prion disease that continues to present a unique problem for medical diagnostics. Uncertainties remain over the prevalence of vCJD in the UK population and its incubation period in individuals of different genotypes. Although the infectious agent that causes vCJD is widely distributed in the peripheral tissues of patients and those carrying the disease, it does not provoke any host immune response that would be amenable to detection. The recent realisation that it can be transmitted by blood transfusion, and that individuals are infectious long before the appearance of symptoms, have increased the need for a blood-screening assay. This paper reviews progress that has been made in the development of potential tests and the protocols that have been devised for their evaluation.
Related Concept Videos
01:21Huntington Disease l: Introduction
02:46Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...